Latest guidelines on the use of long-term HRT confirm the increase in individual health risks for cancer, heart attack infarction and stroke.
recommendations regarding hormone replacement therapy (HRT) for menopause have gone through a very confusing transition in the last decade. These recommendations have changed since the strong support HRT, to discourage strongly, now somewhere in between.
Current thinking on HRT
Most women take HRT estrogen and a progestin / synthetic progestogen. progestogen only added because estrogen causes the lining of the uterus to overgrow, which increases the risk of uterine cancer. The addition of progestin reduces excess risk of uterine cancer, but better protection is the bioidentical natural progesterone which unfortunately does not occur unless women complement each separately. Currently in women who they have had their uterus removed HRT consist of estrogen alone resulting in symptoms of estrogen dominance once again, which can be relieved with bioidentical natural progesterone.
Originally thought that HRT may protect women from heart disease. This course followed by two observations. First, the disease incidence of coronary artery in women substantially increased estrogen levels fall during menopause. Second, the use of hormone replacement therapy in menopausal women causes a favorable change in cholesterol levels and other cardiac risk factors. Therefore, the doctors thought, the decrease in estrogen that accompanies menopause was contributing to the development of coronary heart disease in older women; estrogen replacement (HRT) should help prevent CAD. And for many years HRT was widely recommended and used in menopausal women.
But then, at the beginning of the last decade, this was interrupted largely by the survey data Health Initiative (WHI) on Women, which showed that women receiving hormone replacement therapy with estrogen and progestin actually had a significantly higher risk of heart attacks and strokes, as well as an increase in the formation of blood clots and breast cancer. Women who were able to receive estrogen alone had no increased heart attack or breast cancer, but had an increase in stroke and blood clots.
Why HRT has to be temporary?
HRT should be avoided in any woman who has had breast cancer, CAD, heart attack, stroke, or blood clots. Hormones used in hormone replacement therapy increases the risk of breast cancer. It seems that it takes about 10 years of therapy with estrogen alone to produce an increase in breast cancer, but only five years or so of combined estrogen and progestin to raise the risk of breast cancer.
So virtually all experts recommend that, if HRT is to be used, should be used for less than five years.
This article was originally published on bio-hormone-health, Read the original article here